Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Clin Oral Investig ; 26(2): 1667-1676, 2022 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-34431002

RESUMEN

OBJECTIVES: The primary aims of the present study were (1) to quantify and characterize anaphylactic type I reactions related to local anesthetics (LAs) drawing on the French Pharmacovigilance Database System over a 35-year period and (2) to focuse on reactions associated with dental procedures. The secondary aim was to infer an incidence rate in dental practice. MATERIALS AND METHODS: All cases of anaphylactic reactions were selected using the algorithmic Standardized MeDRA Query "anaphylactic reaction." For each reaction, comprehensive data were collected, in particular the severity of symptoms, risk factors for anaphylaxis, and allergy testing. Imputability was assessed and a crude incidence rate in dental practice was estimated. RESULTS: The first-line search identified 416 anaphylactic reactions, mostly of grade II (138) or III (240) severity. When restricted to dental practice, this number fell to 26 (grade I: 4; grade II: 10; grade III: 11; and grade IV: 1). Lidocaine was most often involved (81.49%) and mostly associated with anaphylactic reactions of grade II and III. Overall, 11 cases of fatal anaphylaxis were recorded, but no in dental practice. In dental practice, lidocaine was also the most frequently involved LA (57.69%). CONCLUSIONS: All these findings highlight the very low incidence of type I-IgE-mediated reactions to LA, particularly in dental practice. The incidence rate of LA anaphylctic episodes in dental practice was estimated as 0.0261 anaphylactic episodes per million LA cartridges. CLINICAL RELEVANCE: True anaphylactic reactions to LAs do occur and may justify a thorough investigation in dental practice.


Asunto(s)
Anafilaxia , Anafilaxia/inducido químicamente , Anafilaxia/epidemiología , Anestésicos Locales/efectos adversos , Humanos , Incidencia , Lidocaína , Estudios Retrospectivos
2.
Int J Obstet Anesth ; 19(3): 331-2, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20627689

RESUMEN

Significant fetal bradycardia occurred when a parturient receiving labor epidural analgesia experienced generalized numbness and tingling, a metallic taste and hot flushes. An emergent cesarean delivery under general anesthesia was performed with favorable outcomes for the mother and baby. The most likely source of the maternal symptoms was spiramycin, which was being administered for treatment of toxoplasmosis.


Asunto(s)
Analgesia Epidural , Analgesia Obstétrica , Anestésicos Locales/efectos adversos , Antibacterianos/efectos adversos , Espiramicina/efectos adversos , Cesárea , Femenino , Terapias Fetales , Humanos , Trabajo de Parto , Errores de Medicación , Parestesia/inducido químicamente , Parestesia/etiología , Embarazo , Resultado del Embarazo , Tetralogía de Fallot/cirugía , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA